NEWS
ATPC and FORMEDIC Technologies Announce Strategic Collaboration to Launch LEGA, a Revolutionary Respiratory Care Device
NASDAQ-listed AGAPE ATP (ATPC) has announced a strategic collaboration with FORMEDIC Technologies to launch LEGA, an electronic chest percussion device for respiratory care.
This partnership aims to address the growing demand for advanced respiratory solutions in a market estimated to reach USD 25.95 billion in 2024 and USD 49.84 billion by 2031.
LEGA, FORMEDIC's flagship product, assists patients with chronic obstructive pulmonary diseases (COPD), pneumonia, bronchiectasis, and other lung-related conditions. The device has already gained traction with nearly 2,000 units used in major hospitals and rehabilitation centres globally.
This collaboration allows ATPC to diversify its wellness portfolio and leverage FORMEDIC's expertise in healthcare technology. The partnership will focus on continuous R&D efforts and joint marketing strategies to position LEGA as a leading respiratory care solution globally.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
2310Followers
105Following
24KVisitors
Follow